Join the club for FREE to access the whole archive and other member benefits.

R42 Group

Company Inventing and Investing in AI, Science and Biotech.

R42 actively invents and finances deep science ventures. We will work with you from the pre-seed inventing stage through to growth stage. We are excited to work with passionate teams who are working to develop revolutionary technology to address pressing needs of our time. Our expertise in science, strategic planning, financing and a global network enables founders to grow and cultivate their ideas into reality.

Visit website: https://www.r42group.com/

 r42group

 r42

 R42group

Details last updated 09-Apr-2020

R42 Group News

Abselion raises 6.6 million to transform protein quantification

Abselion raises 6.6 million to transform protein quantification

BGF - 05-Dec-2024

Investors back Amperia for faster, more accessible protein measurement

Healx secures $47m to advance AI-driven rare disease treatments

Healx secures $47m to advance AI-driven rare disease treatments

Genetic Engineering & Biotechnology News (GEN) - 01-Aug-2024

The UK-based company prepares for clinical trials with its innovative NF1 drug, HLX-1502

Exeter's company SENISCA raises £2 million to treat age-related chronic diseases

Exeter's company SENISCA raises £2 million to treat age-related chronic diseases

University of Exeter - 09-Jun-2022

Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests

Mitrix gains funding to transfuse young mitochondria

Mitrix gains funding to transfuse young mitochondria

Longevity Technology - 28-Jan-2021

Trials on mitochondrial transfusion might help tackle many ageing diseases

R42 group launched $14 million funds aiming to extend longevity

R42 group launched $14 million funds aiming to extend longevity

Longevity Technology - 06-Jan-2021

Funding targets early-stage companies and postdoc researchers with unique ideas

People at R42 Group

Ronjon Nag

Managing Director and Founder at R42 Group